171 related articles for article (PubMed ID: 33545802)
21. [Clinical analysis of the treatment:transcatheter arterial chemoembolization combined with sorafenib in advanced hepatocellular carcinoma].
Li Y; Huang JW; Lu LG; Shao PJ; Hu BS; Huang GM; Wei ZG; Zhang L
Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(31):2187-92. PubMed ID: 21029658
[TBL] [Abstract][Full Text] [Related]
22. [Value of lenvatinib for the treatment of advanced hepatocellular carcinoma].
Yuan B; Wang Y; Zhang JL; Yan JY; Yuan K; Wang XQ; Fu JX; Duan F; Wang MQ
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(11):833-836. PubMed ID: 32234154
[No Abstract] [Full Text] [Related]
23. [Liver Metastasis in a Gastric Cancer Patient--A Case of Successful Radiofrequency Ablation Combined with Degradable Starch Microspheres Transcatheter Arterial Chemoembolization].
Yasumoto T; Yakushiji H; Ohira R; Imamura H; Hirota M; Ohara N; Nakata S; Hatano H; Noda T; Dono K; Oh RJ; Hirabuki N
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1611-3. PubMed ID: 26805113
[TBL] [Abstract][Full Text] [Related]
24. Reduction in Tumor Stain at 2 Weeks after Treatment Initiation Is a Predictor of the Efficacy of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma.
Kunimoto H; Shakado S; Tanaka T; Takata K; Yamauchi R; Fukuda H; Tsuchiya N; Yokoyama K; Morihara D; Takeyama Y; Hirai F; Sakisaka S
Oncology; 2020; 98(11):779-786. PubMed ID: 32877911
[TBL] [Abstract][Full Text] [Related]
25. Correlation between Early Tumor Marker Response and Imaging Response in Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib.
Kodama K; Kawaoka T; Namba M; Uchikawa S; Ohya K; Morio K; Nakahara T; Murakami E; Yamauchi M; Hiramatsu A; Imamura M; Chayama K; Aikata H
Oncology; 2019; 97(2):75-81. PubMed ID: 31242488
[TBL] [Abstract][Full Text] [Related]
26. [Complete Surgical Resection of a Huge Hepatocellular Carcinoma Invading the Diaphragm and Lung after Transcatheter Arterial Chemoembolization (TACE) and Sorafenib--A Case Report].
Mukai Y; Wada H; Eguchi H; Tomokuni A; Tomimaru Y; Asaoka T; Kawamoto K; Marubashi S; Umeshita K; Doki Y; Mori M; Nagano H
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1638-40. PubMed ID: 26805122
[TBL] [Abstract][Full Text] [Related]
27. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
28. [Pre-Operative Treatment with Transcatheter Arterial Chemoembolization (TACE) and Hepatic Arterial Infusion (HAI) for Liver Metastasis from Gastric Cancer--A Case Report].
Tanigawa T; Hasuike Y; Akiyama Y; Higuchi I; Ishikawa A; Okada A; Miyamoto M
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1460-2. PubMed ID: 26805063
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant combined strategy to surgery based on chemoembolization and lenvatinib in hepatocellular carcinoma.
Colón Rodríguez A; Velasco Sánchez E; Rodríguez-Bachiller L; Díaz-Zorita B; López Baena JÁ; Álvarez Luque A; Rincón Rodríguez D; Matilla Peña AM
Gastroenterol Hepatol; 2022; 45(6):490-491. PubMed ID: 34400190
[No Abstract] [Full Text] [Related]
30. [A case of multiple hepatic metastases of gastric cancer that showed complete regression by systemic chemotherapy using paclitaxel and UFT-E].
Okamura H; Fujiwara H; Ichikawa D; Okamoto K; Kikuchi S; Kubota T; Ikoma H; Nakanishi M; Ochiai T; Sakakura C; Kokuba Y; Taniguchi H; Sonoyama T; Otsuji E
Gan To Kagaku Ryoho; 2009 Jun; 36(6):987-90. PubMed ID: 19542721
[TBL] [Abstract][Full Text] [Related]
31. [A Case of Advanced Gastric Cancer with Synchronous Liver Metastases Responding to Preoperative Combination Chemotherapy with S-1 plus Oxaliplatin(SOX)].
Ebisui C; Hamano R; Minoji T; Kitahara T; Yanagisawa T; Okamura S; Fukuchi N; Murata K; Yokouchi H; Kinuta M; Ohishi K
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1263-1265. PubMed ID: 29394601
[TBL] [Abstract][Full Text] [Related]
32. Initial Experience of Ramucirumab Treatment After Lenvatinib Failure for Patients With Advanced Hepatocellular Carcinoma.
Kuzuya T; Ishigami M; Ito T; Ishizu Y; Honda T; Ishikawa T; Fujishiro M
Anticancer Res; 2020 Apr; 40(4):2089-2093. PubMed ID: 32234901
[TBL] [Abstract][Full Text] [Related]
33. Case Report: Successful treatment of advanced hepatocarcinoma with the PD-1 inhibitor Camrelizumab.
Ye W; Cai L; Zhang M; Wu Y; Sun H; Wang YD; Xia Y
Front Immunol; 2023; 14():1221418. PubMed ID: 37575222
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous transvenous shunt occlusion for portosystemic encephalopathy due to lenvatinib administration to a patient with hepatocellular carcinoma and portosystemic shunt.
Namba M; Kawaoka T; Aikata H; Kodama K; Uchikawa S; Ohya K; Morio K; Fujino H; Nakahara T; Murakami E; Yamauchi M; Tsuge M; Hiramatsu A; Imamura M; Baba Y; Awai K; Chayama K
Clin J Gastroenterol; 2019 Aug; 12(4):341-346. PubMed ID: 30706429
[TBL] [Abstract][Full Text] [Related]
35. Obstructive Jaundice Due to Duodenal Ulcer Induced by Lenvatinib Therapy for Hepatocellular Carcinoma.
Suoh M; Hagihara A; Yamamura M; Maruyama H; Taira K; Enomoto M; Tamori A; Fujiwara Y; Kawada N
Intern Med; 2021 Feb; 60(4):545-552. PubMed ID: 33028766
[TBL] [Abstract][Full Text] [Related]
36. Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment.
Yamashige D; Kawamura Y; Kobayashi M; Shindoh J; Kobayashi Y; Okubo S; Muraishi N; Kajiwara A; Iritani S; Fujiyama S; Hosaka T; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Ikeda K; Arase Y; Hashimoto M; Kumada H
Oncology; 2021; 99(3):169-176. PubMed ID: 33207358
[TBL] [Abstract][Full Text] [Related]
37. [A case of a patient with hepatocellular carcinoma who achieved long-term survival after repeated transcatheter arterial chemoembolization and sorafenib therapy].
Mukai R; Wada H; Tomimaru Y; Hama N; Kawamoto K; Kobayashi S; Eguchi H; Umeshita K; Doki Y; Mori M; Nagano H
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1813-5. PubMed ID: 24393931
[TBL] [Abstract][Full Text] [Related]
38. [Clinical observation of the treatment with combination of transcatheter arterial chemoembolization and sorafenib for hepatocellular carcinoma with lung metastasis].
Duan F; Wang MQ; Liu FY; Wang ZJ; Song P
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):716-8. PubMed ID: 20021873
[TBL] [Abstract][Full Text] [Related]
39. Lenvatinib complementary with radioiodine therapy for patients with advanced differentiated thyroid carcinoma: case reports and literature review.
Sheu NW; Jiang HJ; Wu CW; Chiang FY; Chiou HC; Hsiao PJ
World J Surg Oncol; 2019 May; 17(1):84. PubMed ID: 31103041
[TBL] [Abstract][Full Text] [Related]
40. [A Case of Good Quality of Life(QOL)and Favorable Response to Transarterial Chemoembolization(TACE)against Synchronous Multiple Liver Metastases].
Sugimoto K; Sakamoto K; Amemiya K; Tsuchiya Y; Hagiwara T; Matsuzawa H; Makino Y; Motegi S; Kawai M; Ishiyama S; Kamiyama H; Takahashi M; Kojima Y; Tomiki Y; Kuwatsuru R
Gan To Kagaku Ryoho; 2019 Apr; 46(4):730-732. PubMed ID: 31164517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]